J.P. Morgan Healthcare Conference — Jan 13, 2025
At the J.P. Morgan Healthcare Conference, NVIDIA unveiled transformative partnerships with prominent healthcare and life sciences leaders IQVIA, Illumina, Mayo Clinic, and Arc Institute. These collaborations aim to accelerate innovation in genomics, drug discovery, and healthcare services, leveraging NVIDIA’s cutting-edge AI and accelerated computing technologies.
With healthcare evolving into a $10 trillion technology industry, these partnerships signify a pivotal moment in integrating AI with biological data to tackle pressing challenges and enhance patient outcomes. NVIDIA’s advanced solutions enable everything from AI-driven clinical trials and genomic breakthroughs to personalized treatments and next-generation digital pathology.
AI-Powered Solutions Driving Progress
IQVIA: Revolutionizing Clinical Research and Healthcare
IQVIA is harnessing NVIDIA’s AI Foundry service to develop tailored AI solutions powered by over 64 petabytes of healthcare data. These agentic AI models streamline clinical trials, accelerate drug development, and enhance patient care—all while maintaining privacy and regulatory compliance.
“This collaboration with NVIDIA elevates our ability to innovate and deliver faster access to treatments,” said Bhavik Patel, President of Commercial Solutions at IQVIA.
Illumina: Unlocking Genomics’ Full Potential
Global genomics leader Illumina is working with NVIDIA to enhance genomic analysis and expand access to cutting-edge technologies. By integrating NVIDIA’s accelerated computing into the Illumina Connected Analytics platform, researchers and biotech companies worldwide gain new tools to accelerate multiomics data analysis.
“Our partnership will empower life sciences innovators with AI-driven insights for better disease understanding and drug development,” stated Steve Barnard, CTO at Illumina.
Mayo Clinic: Advancing Digital Pathology
Mayo Clinic is deploying NVIDIA’s DGX™ Blackwell systems to develop advanced pathology foundation models. These models leverage 20 million whole-slide images and 10 million patient records, streamlining cancer diagnoses and enabling personalized treatments.
Together, Mayo Clinic and NVIDIA are laying the groundwork for groundbreaking AI applications in diagnostics and therapeutics.
Arc Institute: Scaling Open Science in Biology
Arc Institute is collaborating with NVIDIA to support open science efforts in biology, furthering research capabilities and innovation across computational biology, genomics, and molecular therapeutics.
A New Era for Healthcare and Life Sciences
“AI is unlocking unprecedented opportunities to transform healthcare. Through these collaborations, we are advancing innovation that improves lives globally,” said Kimberly Powell, NVIDIA’s Vice President of Healthcare.
From genomics to clinical trials, NVIDIA and its partners are at the forefront of transforming healthcare and life sciences, catalyzing progress across an industry poised for a future defined by technology.
By
